Congratulations to long-standing client IonOpticks who have recently secured funding from Adelis Equity Partners to continue their product development and expansion into global markets 🚀 We have had the privilege of working closely with the team since early 2019. In this time we have chartered highs and lows, navigating changes to the economic climate and growth ambitions of the business as a leading global producer of high-performance chromatography columns for use in proteomics research and drug discovery. We are very excited about this next stage of growth for IonOpticks and their management team Jarrod Sandow Xavier Perronnet who are undoubtedly pushing the envelope in addressing many of the unresolved health conditions in the medical field. Wishing you every success 🙌 #IonOpticks #Funding #Expansion
IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm. Read more: https://bit.ly/4ekcmN9 IonOpticks is pleased to announce a strategic partnership with Adelis Equity Partners. This investment marks a major step in our growth, helping us strengthen our global presence, expand closer to key markets and continue developing innovative solutions for proteomics research. We've also strengthened our Board with the appointment of several industry heavyweights, including Dr. Peter Wrighton-Smith as Chairman, Marten Winge, Sibel Karina Arnes and Rasmus Molander. By working with Adelis, we’re well-positioned to accelerate our efforts in product development for researchers worldwide, ensuring we remain at the forefront of the industry. IonOpticks CEO, Xavier Perronnet said of the partnership: “We chose to partner with Adelis because they share our vision for IonOpticks' goals and are a strong cultural fit. Their genuine desire to work with us and guide the company to realise its goals, together with their experience, networks, and resources, made them the ideal partner. This partnership allows us to continue developing the best chromatography solutions for researchers worldwide and pursue further innovations tailored to the industry's evolving needs.” For more details on what this partnership means for IonOpticks and our future, read the full press release here: https://bit.ly/4ekcmN9